Toxicities of herbal abortifacients
- PMID: 36924751
- PMCID: PMC10192026
- DOI: 10.1016/j.ajem.2023.03.005
Toxicities of herbal abortifacients
Abstract
Background: In the post-Roe era, barriers to facility-based abortions may lead to an increased incidence of self-managed abortions. While misoprostol-based medication abortions have significant literature supporting its safety profile, there is a knowledge deficit within the medical community regarding the toxicities of commonly used herbal abortifacients.
Methods: This is a narrative review, based on a MEDLINE and HOLLIS database search, of self-managed abortion methods with herbal abortifacients and their associated toxicities.
Results: Common herbal abortifacients with significant morbidity and mortality implications include pennyroyal, blue cohosh, rue, and quinine. Other commonly reported abortifacients considered to be less toxic also are discussed in brief. Special considerations for hepatic, cardiac, renal, and hematologic toxicities are important in patients with significant exposures to these herbal substances.
Conclusion: There is an anticipated increase in the utility of herbal xenobiotics for self-managed abortions with post-Roe restrictions to standard mifepristone-misoprostol protocols. Frontline providers should be aware of the associated toxicities and have special considerations when treating a poisoned patient in this population.
Keywords: Abortifacient toxicity; Emergency care; Herbal abortifacient; Self-managed abortion.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors have no other conflicts of interest or financial disclosures.
Similar articles
-
Toxicity of abortifacients: A review for physicians in the post roe era.Am J Emerg Med. 2022 Nov;61:7-11. doi: 10.1016/j.ajem.2022.08.027. Epub 2022 Aug 18. Am J Emerg Med. 2022. PMID: 36007432 Review.
-
Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019.Issues Law Med. 2021 Spring;36(1):3-26. Issues Law Med. 2021. PMID: 33939340
-
Outcomes During Early Implementation of Mifepristone-Buccal Misoprostol Abortions up to 63 Days of Gestation in a Canadian Clinical Setting.J Obstet Gynaecol Can. 2019 May;41(5):647-652. doi: 10.1016/j.jogc.2018.05.030. Epub 2018 Oct 26. J Obstet Gynaecol Can. 2019. PMID: 31007171
-
Clostridium sordellii toxic shock syndrome after medical abortion with mifepristone and intravaginal misoprostol--United States and Canada, 2001-2005.MMWR Morb Mortal Wkly Rep. 2005 Jul 29;54(29):724. MMWR Morb Mortal Wkly Rep. 2005. PMID: 16049422
-
Second-trimester induction of labor.Clin Obstet Gynecol. 2009 Jun;52(2):188-97. doi: 10.1097/GRF.0b013e3181a2b5d5. Clin Obstet Gynecol. 2009. PMID: 19407525 Review.
References
-
- Nash E State Abortion Policy Landscape: From Hostile to Supportive | Guttmacher Institute. Accessed October 15, 2022. https://www.guttmacher.org/article/2019/08/state-abortion-policy-landsca...
-
- State legislation tracker. Guttmacher Institute. Published October 4, 2021. Accessed October 18, 2022. https://www.guttmacher.org/state-policy
-
- Society of Family Planning Interim Clinical Recommendations Self-Managed Abortion. The Society of Family Planning; 2022. doi:10.46621/ZRDX9581 - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical